Home » Stocks » TRPXY

Therapix Biosciences Ltd. (TRPXY)

Stock Price: $0.120 USD 0.010 (9.09%)
Updated Oct 16, 2020 4:00 PM EDT - End of day

Stock Price Chart

Key Info

Market Cap 1.69M
Revenue (ttm) n/a
Net Income (ttm) -4.58M
Shares Out 14.09M
EPS (ttm) 0.64
PE Ratio 0.19
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 16, 2020
Last Price $0.120
Previous Close $0.110
Change ($) 0.010
Change (%) 9.09%
Day's Open -
Day's Range 0.082 - 0.120
Day's Volume 0
52-Week Range 0.060 - 0.230

More Stats

Market Cap 1.69M
Enterprise Value 971,564
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 14.09M
Float n/a
EPS (basic) 0.64
EPS (diluted) 0.64
FCF / Share -0.39
Dividend n/a
Dividend Yield n/a
Earnings Yield 533.33%
FCF Yield n/a
Payout Ratio n/a
Shares Short 187,878
Short Ratio 0.05
Short % of Float n/a
Beta 0.14
PE Ratio 0.19
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 88.50
Revenue n/a
Operating Income -4.11M
Net Income -4.58M
Free Cash Flow -3.97M
Net Cash 719,000
Net Cash / Share 0.05
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA -119.80%
ROE -9,843.96%
ROIC 685.20%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

Current: $0.120
Target: 18.00
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Operating Income-4.11-7.24-5.75-2.01-1.60-7.04
Net Income-4.58-9.38-6.241.992.54-7.21
Shares Outstanding20414041.0041.00--
Earnings Per Share0.641.201.00-1.00-2.20-9.00
EPS Growth-46.67%20%----
Operating Cash Flow-4.70-7.13-4.58-1.47-1.40-7.36
Capital Expenditures0.720.03-0.04--0.22
Free Cash Flow-3.97-7.11-4.62-1.48-1.40-7.14
Cash & Equivalents0.882.039.220.696.180.66
Total Debt0.160.87----
Net Cash / Debt0.721.169.220.696.180.66
Book Value0.010.198.390.575.11-0.14
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Therapix Biosciences Ltd.
Country Israel
Employees 8
CEO Amitay Weiss

Stock Information

Ticker Symbol TRPXY
Stock Exchange US OTC
Sector Healthcare
Industry Biotechnology
Unique Identifier OTCMKTS: TRPXY
IPO Date March 22, 2017


Therapix Biosciences, a specialty clinical-stage pharmaceutical company, develops drugs based on cannabinoid molecules. Its drug development programs include THX-110, which has completed Phase II a clinical trial for the treatment of Tourette syndrome and Obstructive Sleep Apnea; THX-160, which has completed two preliminary preclinical studies for the treatment of acute and chronic pain; and THX-210 for the treatment of autism spectrum disorder and epilepsy. The company was formerly known as NasVax Ltd. and changed its name to Therapix Biosciences Ltd. in November 2013. Therapix Biosciences Ltd. was founded in 2004 and is headquartered in Givatayim, Israel.